SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001600132-21-000031
Filing Date
2021-06-11
Accepted
2021-06-11 08:31:27
Documents
4
Effectiveness Date
2021-06-11

Document Format Files

Seq Description Document Type Size
1 S-8 blph-20210611xs8.htm S-8 111920
2 EX-5.1 blph-20210611ex51c6e04ed.htm EX-5.1 11259
3 EX-23.2 blph-20210611ex232ab3850.htm EX-23.2 3313
4 GRAPHIC blph-20210611ex51c6e04ed001.jpg GRAPHIC 2902
  Complete submission text file 0001600132-21-000031.txt   131770
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257007 | Film No.: 211010024
SIC: 2834 Pharmaceutical Preparations